ZVSA — Zyversa Therapeutics Share News
0.000.00%
Last trade - 00:00Brief: Zyversa Says European Patent Office To Grant Co's Patent Application For Cholesterol Transport Mediator VAR 200
Brief: ZyVersa Therapeutics Reports Q1 2023 Corporate And Financial Results
Brief: ZyVersa Therapeutics Inc Announces Closing Of $11 Mln Public Offering
Brief: Zyversa Therapeutics Reports Inducement Grant To Newly Appointed Chief Medical Officer Under Nasdaq Listing Rule 5635(C)(4)
Brief: Zyversa Therapeutics Appoints Three New Board Members
Brief: Zyversa Therapeutics Files For Offer And Sale From Time To Time By Selling Securityholders Of Up To 15.19 Million Shares Of Common Stock - SEC Filing
Brief: SEC Says "Effective" For Business Combination Of Larkspur Health Acquisition Corp And Zyversa Therapeutics
Brief: Zyversa Therapeutics And Larkspur Health Acquisition Corp. Announce Business Combination, Interim Financing And Pipe Investment Update
Brief: ZyVersa Therapeutics To Become A Publicly Traded Biopharma Company Via Merger With Larkspur Health Acquisition Corp.